KCRS22 Session Seven: Immunotherapy Advances and Research at Kidney Cancer Research Summit

At KCRS22, Ari Hakimi and Hans Hammers moderate the presentations and discussion surrounding immunotherapy in kidney cancer treatment. • Understanding and targeting the myeloid response in ccRCC – Ari Hakimi, Memorial Sloan Kettering Cancer Center • A Functional Genomics Approach to Identify Renal Cell Carcinoma Antigens Targeted by T Cells in the Tumor Microenvironment – Edus Warren, Fred Hutchinson Cancer Research Center • Overcoming Resistance to Immunotherapy in Renal Cancer by Targeting Telomerase – Esra Akbay, UTSW • New modes of cancer targeting by dissection of successful immunotherapy – Andrew Sewell, Cardiff University* Guest speaker, Andrew Sewell, PhD, Cardiff University, Professor, Division of Infection and Immunity. Mechanisms of Immunity Theme Lead, Systems Immunity Research Institute. Presentation COMING SOON! If you'd like to be notified when Dr. Sewell's presentation is available, be sure to subscribe to our YouTube channel. All KCRS22 slides, video, program information, and pre-registration for KCRS23 can be found at www.kcrs.kidneycan.org